Success Story: 14-Day EB1A Approval! Instructor Reaches Milestone with Our Expert Support
Client’s Testimonial:
“I am truly grateful to the NAILG team for their outstanding professionalism, responsiveness, and deep understanding of the EB-1A process. Their strategic guidance helped me present my work in the most compelling way, and I was thrilled to receive approval without an RFE. Thanks to their support, I can now continue my research and contribute to the field of cardiovascular medicine here in the United States.”
On June 27th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for an Instructor in the Field of Cardiovascular Medicine (Approval Notice).
General Field: Cardiovascular Medicine
Position at the Time of Case Filing: Instructor
Country of Origin: Belgium
State of Residence at the Time of Filing: California
Approval Notice Date: June 27th, 2025
Processing Time: 14 days (Premium Processing Requested)
Case Summary:
We are pleased to share the success story of an EB1A (Alien of Extraordinary Ability) approval granted to a cardiovascular medicine researcher from Japan whose work is helping advance therapeutic strategies for heart failure and myocardial infarction. At the time of filing, the client was employed as a researcher developing extracellular vesicle-based therapies for cardiac dysfunction and had already made groundbreaking contributions to stem cell technology and mitochondrial biology. The petition was filed under premium processing and approved in just 14 days.
Well-Positioned to Advance the Proposed Endeavor:
When this client approached NAILG, we immediately recognized his strong candidacy due to his distinctive specialization in cardiovascular drug development through stem cell cardiomyocyte-derived mitochondrial-rich extracellular vesicles (M-EVs). His work has focused on restoring cardiac performance in myocardial infarctions by harnessing innovative cellular therapy approaches. After reviewing his extensive research background and impact on the field, we successfully demonstrated his extraordinary ability to USCIS.
Research with Substantial Merit and National Importance:
The client’s research targets a critical need in regenerative cardiovascular medicine, improving mitochondrial function in damaged cardiac tissue through stem-cell-derived vesicles. His scholarly output includes 15 peer-reviewed journal articles, 13 first-authored abstracts, 2 preprints, and 1 book chapter. His work has been cited 1,274 times, and he has completed at least 29 peer reviews for prestigious journals. The petition outlined how his original discoveries in cardiac repair have enabled further scientific progress in areas like ischemic stroke, myocardial repair, and chronic wound treatment.
Supportive Expert Testimonials:
The petition was further strengthened with 4 letters of recommendation from distinguished researchers in the field, including three independent advisory opinions. These experts confirmed the impact, originality, and global relevance of the client’s work.
“It is crucial to support the continuation of [Client’s] work for the advancement of cardiovascular medicine research and for the benefit of the nation.”
Final Result:With strong documentation of his original scientific contributions, high-impact authorship, and global influence in cardiovascular medicine, the EB1A petition was approved within just two weeks of filing. We are proud to have helped another extraordinary researcher continue his innovative work in the United States through our professional guidance at NAILG.